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Available online xxxxIntroduction: The persistence of schizophrenia in human populations separated by geography and time led to the
evolutionary hypothesis that proposes schizophrenia as a by-product of the higher cognitive abilities of modern
humans. To explore this hypothesis,weusedhere an evolutionary epigenetics approach building on differentially
methylated regions (DMRs) of the genome.
Methods: We implemented a polygenic enrichment testing pipeline using the summary statistics of genome-
wide association studies (GWAS) of schizophrenia and 12 other phenotypes. We investigated the enrichment
of association of these traits across genomic regions with variable methylation between modern humans and
great apes (orangutans, chimpanzees and gorillas; great ape DMRs) and between modern humans and recently
extinct hominids (Neanderthals and Denisovans; hominid DMRs).
Results: Regions that are hypo-methylated in humans compared to great apes show enrichment of association
with schizophrenia only if themajor histocompatibility complex (MHC) region is included.With theMHC region
removed from the analysis, only a modest enrichment for SNPs of low effect persists. The INRICH pipeline con-
firms this finding after rigorous permutation and bootstrapping procedures.
Conclusion: The analyses of regions with differential methylation changes in humans and great apes do not pro-
vide compelling evidence of enrichment of associationwith schizophrenia, in contrast to our previousfindings on
more recent methylation differences between modern humans, Neanderthals and Denisovans. Our results fur-
ther support the evolutionary hypothesis of schizophrenia and indicate that the origin of some of the genetic sus-
ceptibility factors of schizophrenia may lie in recent human evolution.








Schizophrenia is a psychiatric disorder with a prevalence rate of
2.7–8.3/1000 persons (Messias et al., 2007) and heritability estimated
between 60 and 90% (Cardno et al., 1999; Lichtenstein et al., 2009;
Skre et al., 1993; Sullivan et al., 2003). It occurs at quite similar rates
across populations worldwide (Ayuso-Mateos, 2002; Brüne, 2004;
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ia Research, https://doi.org/1back 5000 years (Jeste et al., 1985). This consistent persistence of the
disease despite reduced fecundity (Brüne, 2004; Essen-Mӧller, 1959;
Lewis, 1958; Macsorley, 1963; Nichols, 2009; Power et al., 2013;
Stevens, 1969) and increased mortality is a paradox (Bassett et al.,
1996; Brown, 1997; Larson and Nyman, 1973), since the reduced fecun-
dity of patients afflicted with schizophrenia does not appear to elimi-
nate the disease from the population (Power et al., 2013). Part of the
reason may be due to afflicted individuals reproducing prior to the
onset of the disease (Markow, 2012). Another contributing factor
could be that schizophrenia risk variants may have provided an advan-
tage to the kin of the affected by conferring superior creative and intel-
lectual abilities upon them (Kyaga et al., 2011; Nichols, 2009). To
explain the constant occurrence of the disease, the concept of an evolu-
tionary basis for the disorder was initially put forward by Essen-Mӧller
(1959) and Huxley et al. (1964). The version that is best known, wasthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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2 N. Banerjee et al. / Schizophrenia Research xxx (xxxx) xxxhowever postulated by TJ Crow (Crow, 1997, 1995) who proposed the
so-called evolutionary hypothesis of schizophrenia that suggests that
the disease is a consequence of human evolution: the higher cognitive
abilities of modern-day humans, including language, may predispose
to psychiatric illnesses such as schizophrenia (Crow, 2008, 2000, 1997).
In the post-genomic era (Lander et al., 2001; Venter et al., 2001),
emerging lines of evidence are lending support to this hypothesis.
Crespi et al. (Crespi et al., 2007) were among the first to show that
genes with evidence of recent positive selection in humans are also im-
plicatedmore frequently in schizophrenia.More evidence has been pro-
vided by studies based on comparative genomics (Pollard et al., 2006;
Srinivasan et al., 2016; Xu et al., 2015), a field in which genomes of pro-
gressively older species are compared to identify substitutions and mu-
tations that help estimate divergence between the species. For instance,
a group of regions defined by negative Neanderthal selective sweep
(NSS) scores describe the selective evolution of genomic regions in
modern-day humans over Neanderthals (Burbano et al., 2010; Green
et al., 2010). These regions were shown by (Srinivasan et al., 2016) to
be enriched for schizophrenia riskmarkers, in linewith the evolutionary
hypothesis of schizophrenia. Other regions known as human acceler-
ated regions (HARs) (Gittelman et al., 2015; Pollard et al., 2006; Xu
et al., 2015), first described by (Pollard et al., 2006), show accelerated
evolution in humans compared to primates or mammals. HARs have
also provided some evidence of enrichment of association with schizo-
phrenia (Xu et al., 2015), but these findings may have been driven by a
few genes since they were not replicated using a polygenic approach
(Srinivasan et al., 2017, 2016).
While several studies have looked at the evolution of the genome
(Bird et al., 2007; Bush and Lahn, 2008; Gittelman et al., 2015; Paaby
and Rockman, 1990; Pollard et al., 2006), there are reports that the epi-
genome is evolving as well (Gokhman et al., 2014; Hernando-Herraez
et al., 2015, 2013;Mendizabal et al., 2014;Molaro et al., 2011). This pro-
vides new insights into events leading to the speciation and divergence
of modern humans. The epigenome refers to the layer of chemical mod-
ifications, such asmethylation andhistonemodifications, to the genome
that regulate gene expression (Bernstein et al., 2007; Kundaje et al.,
2015; Rivera and Ren, 2013). For instance, (Gokhman et al., 2014) com-
pared the methylomes of humans with Neanderthals and Denisovans.
They reported that while 97% of the methylome was comparable be-
tween humans, Neanderthals and Denisovans, some regions showed
differential methylation between the three hominids. Previously
(Banerjee et al., 2018), we analysed the differentially methylated re-
gions (DMRs) identified for Neanderthals, Denisovans and modern
humans by (Gokhman et al., 2014), and found evidence that the regions
of the genome with human-specific DMRs harbour relatively more ge-
netic variants associated with schizophrenia than the rest of the ge-
nome, i.e. the DMRs were enriched for SCZ markers both at the single-
nucleotide polymorphism (SNP) level and at the gene level. These
human-specific DMRs thus provide evidence of enrichment of methyla-
tion changes in regions harbouring genetic variants associated with
schizophrenia, at least since the divergence from Neanderthals and
Denisovans (Banerjee et al., 2018).
Here,we sought to determine if evolutionarily oldermethylation dif-
ferences can provide a further timeframe for the origin of schizophrenia
risk markers in the human lineage. We asked whether we can find epi-
genetic evidence that the origin of schizophrenia risk markers predates
the origins of theHomogenus, i.e. before thedivergence of chimpanzees
and humans around 6–8 million years ago (MYA) (Glazko and Nei,
2003; Langergraber et al., 2012).We tested this hypothesis by analysing
great ape DMRs that trace an evolutionary history of at least 13 million
years (Glazko and Nei, 2003; Hasegawa et al., 1985; Rannala and Yang,
2003). We used the same statistical analyses as described by (Lee et al.,
2012; Schork et al., 2013; Srinivasan et al., 2016) to test for polygenic
enrichment of a set of markers from genome-wide association studies
(GWAS). We interrogated regions of the human genome which are
hypo- or hyper-methylated in comparison to the corresponding onesPlease cite this article as: N. Banerjee, T. Polushina, F. Bettella, et al., An
hominids provides support fo..., Schizophrenia Research, https://doi.org/1in chimpanzees, gorillas and orangutans for enrichment of genetic var-
iants associated with schizophrenia or other human traits.2. Materials and methods
2.1. GWAS data
Summary statistics for thirteen different phenotypes were obtained
from their respective published GWAS studies: schizophrenia (SCZ)
(Ripke et al., 2014), bipolar disorder (BPD) (Sklar et al., 2011), attention
deficit hyperactivity disorder (ADHD) (Demontis et al., 2017), rheuma-
toid arthritis (RA) (Stahl et al., 2010), blood lipid markers (high density
lipoprotein (HDL), low density lipoprotein (LDL), triglycerides (TG),
total cholesterol (TC)) (Teslovich et al., 2010), blood pressure (systolic
blood pressure (SBP), diastolic blood pressure (DBP)) (Ehret et al.,
2011), body mass index (BMI) (Locke et al., 2015), height (Wood
et al., 2014) and intelligence (Sniekers et al., 2017). For studies pub-
lishedwith hg18 coordinates (BPD, SBP, DBP, HDL, LDL, TG, TC, RA), con-
version to hg19 was performed using the command line version of the
liftOver tool from the UCSC Genome Browser (Karolchik et al., 2014)
(http://hgdownload.cse.ucsc.edu/downloads.html#utilities_
downloads). For BMI and height SNPs, the genomic coordinates were
obtained by mapping them to the assembly of 1000 Genomes Project
(1KGP) Phase 1 reference panel SNPs (Durbin et al., 2012).2.2. Human hypo- and hyper-methylated regions (from great ape DMRs)
These methylated regions were retrieved from the study by
Hernando-Herraez et al. (2013), who identified them by comparing
themethylation profile of DNA fromperipheral blood samples of orang-
utans, chimpanzees and gorillas to that of humans. They provide both
hypo- and hyper-methylated DMRs for humans that were analysed in
this study. As these DMRs are identified in the same tissues in all sam-
ples, they are considered to represent species-specific methylation dif-
ferences, not tissue-specific methylation differences (Gokhman et al.,
2014)., The human hypo- and hyper-methylated DMRs can be used to
represent an evolutionary course of history spanning from at least
13MYA (Glazko and Nei, 2003; Langergraber et al., 2012), when orang-
utans diverged from the common ancestors, to 6 MYA, when the chim-
panzees and humans diverged from each other (Glazko and Nei, 2003;
Langergraber et al., 2012). Since our interest was in human-specific en-
richment, we focused the analyses on human hypo- and hyper-
methylated DMRs. For the sake of brevity and because these human
hypo and hyper-methylated DMRs are derived by comparing against
great apes, we refer to these DMRs simply as ‘great ape DMRs’.2.3. Differentially methylated regions (DMRs) from Neanderthals,
Denisovans and modern humans (hominid DMRs)
As previously described (Gokhman et al., 2014), these methylated
regions have been identified by comparing the methylomes of osteo-
blasts from modern-day humans with those from Neanderthals and
Denisovans Since these human-specific DMRs are obtained by compar-
ing against other hominid species, we refer to them as ‘hominid DMRs’
to allow easy comparison with great ape DMRs. Gokhman et al. (2014)
devised a strategy utilizing information in the form of cytosine (C) to
thymine (T) ratios to decipher the ancientmethylomes of Neanderthals
and Denisovans. Subsequently, they compared the methylomes of Ne-
anderthals, Denisovans and modern humans and inferred the species
in which the methylation variation likely took place; this information
was used to classify the DMRs as Neanderthal-specific, Denisovan-
specific and human-specific. These DMRs represent species-specific
methylation (Gokhman et al., 2014).alysis of differentially methylated regions in great apes and extinct
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We obtained NSS marker data from (Srinivasan et al., 2016). Nega-
tive scores for NSS markers indicate positive selection in humans.
Markers with such scores were used in the downstream analyses.
2.5. SNP assignment with LDsnpR
The previously published R-based software package LDsnpR
(Christoforou et al., 2012) was utilized for assigning SNPs to the respec-
tive DMRs using LD (linkage disequilibrium)-based binning at r2 ≥ 0.8 in
R (Team, 2017). LD-based binning makes it possible to determine
whether SNPs from a specific GWAS are in LDwith the DMR of interest.
Using LD allows the capture of a greater number of relevant SNPs in
comparison to an approach where only physically overlapping SNPs
are considered. The LD file utilized was in HDF5 format and was con-
structed from the European reference population of 1KGP and can be
publicly downloaded at: http://services.cbu.uib.no/software/ldsnpr/
Download.
2.6. Enrichment analyses based on stratified quantile-quantile (QQ) plots
QQ plots are an essential method used in GWASs to depict the pres-
ence of true signals. They help to visually observe the spread of data and
deviations from the null distribution. Under the null hypothesis, no dif-
ference is expected between the observed and expected distributions of
data. As such, a line of no difference or null line is obtained that is equi-
distant from both X and Y axes. However, if the null hypothesis were to
be false, there would be a deviation of the observed data distribution
from the expected data distribution. As described in depth by (Schork
et al., 2013), a leftward deflection of the observed distribution from
the null line represents enrichment – the greater the leftward deflec-
tion, the stronger the enrichment of true signals. This method has
been used recently not only to show how specific genomic annotation
affects the distribution of disease SNPs with true signals (Schork et al.,
2013), but also to demonstrate that regions of recent evolution are
enriched for schizophrenia markers (Banerjee et al., 2018; Srinivasan
et al., 2016). We took the SNPs that are in LD with the DMR regions
and plotted their p-value distributions from various GWASs. The ob-
served p-value distributions were then determined to be enriched or
not using conditional Q-Qplots as described by (Schork et al., 2013). Ge-
nomic inflation was corrected by λGC.
2.7. INRICH-based enrichment analysis
The stratified QQ plots provide a visual depiction of data distribu-
tions and enrichment of true signals within a stratum of data, but they
do not quantify this enrichment. Therefore, we used the INterval En-
RICHment (INRICH) analysis tool to statistically quantify the enrich-
ment observed. This pipeline performs permutation and bootstrapping
procedures to determine with statistical confidence whether LD-
implicated genomic intervals are enriched in specific gene sets (Lee
et al., 2012). The INRICH analysis takes into account several potential
biases that can otherwise lead to false positives, such as variable gene
size, SNP density within genes, LD between andwithin genes, and over-
lapping genes in the gene sets. We used the same procedure reported
previously (Banerjee et al., 2018; Xu et al., 2015) with SNPs in the ex-
tended MHC region and SNPs with MAF b 0.05 excluded from the anal-
ysis. Additional details can be found in the Supplementary information.
2.8. Plan of analyses
In this study,wemade use of publicly available GWAS data from sev-
eral phenotypes together with measures of genome evolution. We first
intersected regions of great ape DMRs that tagged markers from GWAS
of various traits using LDsnpR. We followed this up with polygenicPlease cite this article as: N. Banerjee, T. Polushina, F. Bettella, et al., An
hominids provides support fo..., Schizophrenia Research, https://doi.org/1enrichment testing using stratified QQ plots. Subsequently we per-
formed enrichment analyses using INRICH wherein we tested gene
sets flanking great ape DMRs for over-representation of LD-implicated
genome intervals. This flowchart is depicted in Supplementary Fig. 1.
3. Results
3.1. Co-localisation of human hypo-methylated regions and genetic vari-
ants associated with schizophrenia in the MHC
Following the plan of analysis as depicted in Supplementary Fig. 1,
we ascertained whether there is any enrichment of human hypo- and
hyper-methylated regions in schizophrenia-associated SNPs. Using pre-
viously published methodology (Christoforou et al., 2012), we mapped
schizophrenia markers to human hypo-methylated regions (hypo-
DMRs) and hyper-methylated regions (hyper-DMRs). Out of a total of
~9.4 million SCZ markers obtained from the GWAS, 10,165 markers
tagged hypo-DMRs and 4503 tagged hyper-DMRs.
Fig. 1A shows the conditional QQ plots for schizophrenia markers
(all markers, the hypo-DMR set and the hyper-DMR set) including
those in the MHC region. For hypo-DMR markers (Supplementary
Dataset 1),we observed a significant enrichment as depicted by the left-
ward deviation. No enrichment was observed for hyper-DMR markers.
Since the MHC region is a region of extended linkage disequilibrium,
which can bias the enrichment estimates, and since it is themain region
of association with schizophrenia, we also tested the enrichment with
the MHC region removed (Fig. 1B). Under these conditions there is a
trend for enrichment of hypo-DMR markers at higher p-value thresh-
olds, but this enrichment is substantially less than when the MHC is in-
cluded (Fig. 1A).
3.2. Enrichment of markers is not seen for other human traits
Next, we tested if the human hypo- and hyper-methylated regions
are enriched for other human traits and phenotypes. We tested a total
of thirteen different phenotypes, full details of which can be found in
Section 2.1. Each GWAS had been performed with a different number
of genotyped SNPs, and this difference could potentially bias our results.
To circumvent this, we created a list of ~2.4 million common SNPs that
were genotyped across all the phenotypes investigated in the present
study. Only SNPs on this list were used for enrichment analysis.
As can be seen in Fig. 2, no enrichment was observed in any of the
traits, with the possible exception of height at higher p-value threshold
markers. The common list of markers did not contain the MHC region
and as such no enrichment is observed for schizophrenia either.
3.3. Evidence of enrichment for hypo-methylated regions with SNPs at high
p-values
The enrichment plots allowed us to visually ascertain enrichment in
the datasets. However, they did not give any indication of the statistical
robustness of the enrichment. To ascertain if the human hypo- and
hyper-methylated regions are statistically enriched for schizophrenia
and height markers, we implemented the INRICH pipeline, which per-
forms 10,000 permutations and 5000 bootstrapping calculations, to de-
termine with statistical confidence the enrichment observed (Lee et al.,
2012).
The INRICH analysis confirmed a significant (p b 0.05) enrichment of
association for human hypo-DMRs, but not hyper-DMRs, with schizo-
phrenia at SNPs of higher p-value thresholds (p b 10e-3 to p b 10e-4)
(Fig. 3). This enrichment was at the gene level, and complemented the
enrichment observed at the SNP level for higher p-value thresholds
(Fig. 1B). Importantly, this enrichment persisted upon testing a pruned
schizophrenia dataset (Supplementary Fig. 2). The enrichment was
however not significant at the genome-wide threshold (p b 5x10e-8)
and was much weaker than that observed for hominid DMRs (Fig. 3).alysis of differentially methylated regions in great apes and extinct
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Fig. 1. Enrichment plots of hypo-DMR and hyper-DMR SNPs in schizophrenia Quantile-quantile (QQ) plots of GWAS SNPs for Schizophrenia (SCZ) with the extended MHC region (chr6:
25-35Mb) unmasked (A) andmasked (B). Expected -log10 p-values under the null hypothesis are shownon theX-axis. Observed -log10 p-values are on the Y-axis. The values for all GWAS
SNPs are plotted in dark green while the values for SNPs in linkage disequilibrium (LD)with hypo-methylated DMRs are plotted in blue and SNPs in LDwith hyper-methylated DMRs are
plotted in pink. These DMRs are part of the great ape DMR dataset. A leftward deflection of the plotted p-values from the line for all GWAS SNPs indicates enrichment of true signals – the
greater the leftwarddeflection, the stronger the enrichment. Genomic correctionwas performedon all SNPswith global lambda. (For interpretation of the references to colour in thisfigure
legend, the reader is referred to the web version of this article.)
Fig. 2. Enrichment plots of hypo-DMR and hyper-DMR SNPs across multiple traits Thirteen different GWASs were analysed using a common set of ~2.4 million SNPs. The p-values for the
common set of GWAS SNPs are plotted in dark green; p-values for SNPs that tag hypo-methylated DMRs are plotted in blue; and p-values for SNPs that tag hyper-methylated DMRs are
plotted in pink. These DMRs are part of the great ape DMR dataset. ADHD, attention deficit hyperactivity disorder; BMI, bodymass index; BPD, bipolar disorder; DBP, diastolic blood pres-
sure; HDL, high density lipoprotein; LDL, low density lipoprotein; RA, rheumatoid arthritis; SBP, systolic blood pressure; SCZ, schizophrenia; TC, total cholesterol; TG, triglycerides. The
MHC region was absent from the common set of SNPs. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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Fig. 3. INRICH test for enrichment of association of DMR gene sets andNSS geneswith SCZ,MHCmaskedA visual heatmapdepicting p-values from bootstrappingwith 5000 iterations. The
various evolutionary annotations compared are as follows. HypoDMR – human hypo-methylated DMRs; HyperDMR – human hyper-methylated DMRs. HypoDMR and HyperDMR were
taken from the study by Hernando-Herraez et al. (2013). dmrH – human-specific DMRs (Gokhman et al., 2014), which are referred to as hominid DMRs in this manuscript. NSS - Nean-
derthal selective sweep. Datasets marked with * have been previously reported by (Banerjee et al., 2018) and are presented here for comparison only.
5N. Banerjee et al. / Schizophrenia Research xxx (xxxx) xxxWe also observed a similar trend for height where there was enrich-
ment at SNPs of higher but not lower p-value thresholds. This enrich-
ment was similarly less pronounced than for hominid DMRs
(Supplementary Fig. 3).
4. Discussion
In our study, we investigated if regions of the human genomewhose
methylation has evolved since the divergence of modern humans from
great apes are enriched for markers of schizophrenia. We found evi-
dence that there is enrichment for hypo-methylated DMRs in the ex-
tended MHC locus, a known risk region that harbours the most
significant schizophrenia GWAS markers (Ripke et al., 2014). When
the MHC region was excluded from the analysis, there remained a
trend towards enrichment of hypo-DMRs driven by SNPs of higher p-
value thresholds but not genome wide p-value thresholds. This finding
was complemented by the INRICH analyses that indicated significant
enrichment among SNPs of higher p-value thresholds. However, in con-
trast to our previous finding, (Banerjee et al., 2018), the enrichment ob-
served for hypo-DMRs is largely driven by theMHC region andnot other
genomic regions. In theprevious paper (Banerjee et al., 2018), excluding
the MHC region from analyses does not preclude genome-wide signifi-
cant enrichment.
When analysing a global SNP list common to GWAS of several traits,
we failed to find evidence of enrichment of any trait with the possible
exception of height at higher SNP p-value thresholds.We tested this fur-
ther with the INRICH pipeline, which revealed gene-level enrichment of
LD intervals for height markers below the genome-wide threshold (p
b 5 × 10e-8). Compared to our previous study that analysed hominid
DMRs (Banerjee et al., 2018), the great ape DMRs tested here show far
less enrichment. The great ape and hominid DMRs have very little over-
lap, which suggests that the methylation changes that took place since
the divergence of modern humans from Neanderthals and Denisovans
occurred in different regions of the genome compared to those that
took place since divergence from great apes.
The central role of the MHC region in the enrichment of human
hypo-methylated regions poses interesting questions. The MHC region
is known for its complex LD architecture, which renders thePlease cite this article as: N. Banerjee, T. Polushina, F. Bettella, et al., An
hominids provides support fo..., Schizophrenia Research, https://doi.org/1interpretation of genetic signals very challenging. Other groups have
previously reported that the MHC region is one of the fastest evolving
regions of the human genome (Meyer et al., 2017) and have implicated
it inmate preference (Bernatchez and Landry, 2003; Kromer et al., 2016;
Potts andWakeland, 1990; Roberts et al., 2008;Winternitz et al., 2017),
odour perception (Roberts et al., 2008; Santos et al., 2005) and immune
response (Benacerraf, 1981; Horton et al., 2004). Recently it was shown
that a large proportion of the association of the region with schizophre-
nia can be explained by complement C4haplotypes that includeC4 copy
number variation (Sekar et al., 2016). Nevertheless, there remains a part
of the association in this region that is unexplained (Gejmanet al., 2011)
and will need further investigation. Furthermore, as reported by Pouget
et al. (2016), compared to other autoimmune diseases, there is no en-
richment of immune loci outside the MHC region in schizophrenia sug-
gesting a highly localised enrichment of loci in this region. It is
interesting to consider the possibility that the MHC region and the im-
mune system in general play a central role in evolution at the
epigenomic as well as at the genomic level (Meyer et al., 2017; Potts
andWakeland, 1990; Sommer, 2005; Traherne, 2008). Themechanisms
by which hypo-methylation could influence the aforementioned pro-
cesses are open to speculation since the MHC region has N200 genes
in close physical proximity and LD with one another (Beck et al.,
1999). This makes it hard to interpret the exact biological consequences
of our findings. In general, hypo-methylation usually is observed in ac-
tive regions of the genome such as transcription start sites (TSS) while
hyper-methylation is found in gene bodies (Wagner et al., 2014). One
may speculate that a global shift in the methylation patterns of the ex-
tended MHC region towards hypo-methylation suggests higher activa-
tion of the genes contained therein. However, it is also known that
hypo-methylation may in fact induce transcriptional repression (Hon
et al., 2012). Future research should try to unravel the interplay be-
tween hypo and hyper-methylation in the regulation of the extended
MHC region.
The immune system is also implicated in brain lateralization
(Meador et al., 2004; Sumner et al., 2011) and handedness (Morfit
and Weekes, 2001) that are implicated in schizophrenia as well
(Venkatasubramanian and Debnath, 2014). Recently it was shown
that methylation of specific genes can predict handedness (Schmitzalysis of differentially methylated regions in great apes and extinct
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hypo-methylation in the extended MHC region affects handedness and
brain lateralization. Since we analyse the dataset from the schizophre-
nia GWAS, all the sub-phenotypes associated with brain volume
would be correlated with schizophrenia as well.. Thus the genetic vari-
ants from the GWAS data also affect the broader phenotypic changes
observed in patients with schizophrenia such as brain morphology
(Lee et al., 2016; Smeland et al., 2017).
Interestingly, the gene-level analysis via INRICH seems to suggest
enrichment of SNPs of higher p-value thresholds in great ape DMRs
for both schizophrenia and height. This enrichment is far lower than
what we found for hominid DMRs for both schizophrenia and height
(Banerjee et al., 2018) and which persisted for schizophrenia even
with pruned datasets. However, height and schizophrenia have a ge-
netic overlap (Bacanu et al., 2013) and epidemiological studies have
shown such genetic loci are discordant for direction of effect (Gunnell
et al., 2005; Zammit et al., 2007). Future research should therefore, in-
vestigate whether the same genetic loci are driving the enrichment ob-
served in both great ape and hominid DMRs for height and
schizophrenia.
The very small overlap between great ape and hominid DMRsmight
suggest that the divergence fromNeanderthals andDenisovans brought
aboutmore significantmethylation changes in regions implicated in the
aetiology of schizophrenia and height than the divergence from great
apes. In other words, our results might suggest that the evolutionary
factors that regulate methylation variation acted on different segments
of the genome at different time points. So while the methylation varia-
tion since the divergence from Neanderthals and Denisovans maymark
a genome-wide increase of schizophrenia susceptibility(Banerjee et al.,
2018), the methylation variation from the time period between 13 and
6 MYA appears not to have significantly increased the risk for schizo-
phrenia (except possibly for some markers in the MHC region).
Our results are also in line with the findings of (Srinivasan et al.,
2017), who failed to find evidence of enrichment of schizophrenia
using genomic markers of evolution dating back to 200 MYA. Bigdeli
et al. (2013) came to a similar conclusion using genomicmarkers of evo-
lution derived from great apes that failed to show enrichment for
schizophrenia causal variants. In contrast, evidence exists of enrichment
of regions of recent human evolution for schizophrenia variants, possi-
bly from the time of divergence of common ancestors of humans and
Neanderthals (Srinivasan et al., 2016). Interestingly, one of the evolu-
tionary proxies used by Srinivasan et al. (2017), namely HARs, also
showed enrichment for height, similar to our recent study (Banerjee
et al., 2018). This may suggest that regions controlling both genomic
and epigenomic variation in height may also be driven by recent evolu-
tion. Finally, our results agree well with the observation by (Srinivasan
et al., 2017) of some involvement of the MHC in an early evolutionary
context.
Although our results are in linewith several findings in the field, the
current methods have some limitations. Highly polygenic traits such as
schizophrenia have a large number of genetic loci contributing to the
aetiology of a disease (Bulik-Sullivan et al., 2015; Schork et al., 2016).
The ability to detect these large numbers of genetic loci is dependent
on the sample size and adequate statistical power (Schork et al.,
2016). Consequently, the polygenic enrichment methods may be lim-
ited by the statistical power of the respective GWAS and trait
polygenicity. Furthermore, in the INRICH analysis that uses LD-
clumping of SNPs at p b 10e-3 to p b 10e-8, higher p-value thresholds
(e.g. p b 10e-3) still include SNPs of lower p-values, even though they
become progressively smaller minorities. Thus, although higher p-
values increase the number of LD-clumps tested, we do not expect
this to increase the Type I error rate (Lee et al., 2012).
Research into methylation of schizophrenia has revealed that pa-
tients tend to have widespread aberrant methylation (Hannon et al.,
2016; Jaffe et al., 2016) with local hyper-methylation of specific genes
(Yasui et al., 2016) and that antipsychotic administration partiallyPlease cite this article as: N. Banerjee, T. Polushina, F. Bettella, et al., An
hominids provides support fo..., Schizophrenia Research, https://doi.org/1reverses the global hypo-methylation (Yasui et al., 2016). To determine
whether the evolutionary methylated regions in the form of great ape
and hominid DMRs also play a role in the aetiology of the disease, future
research should investigate their methylation status in actual patient
samples.
In conclusion, our results suggest that methylation markers tracing
an evolutionary period dating back to 13 MYA (great ape DMRs) are
not enriched for schizophrenia markers, unlike methylation markers
from a recent timeframe (hominid DMRs) (Banerjee et al., 2018).
Taken in consideration with previous studies of genomic markers of
evolution dating back 200 MYA (Srinivasan et al., 2017), our results
help narrow down the evolutionary window of the origins of schizo-
phrenia to more recent evolutionary events, possibly after the diver-
gence of modern-day humans from Neanderthals and Denisovans.
Using epigenomics approaches, we therefore help refine the evolution-
ary hypothesis of schizophrenia as posited by T.J Crow and provide evi-
dence to evolution playing a role in the persistence of schizophrenia.
Supplementary data to this article can be found online at https://doi.
org/10.1016/j.schres.2018.11.025.
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